Celldex Therapeutics, Inc.
CLDXNasdaqCIK 744218HealthcareFiscal year ends Dec 31
Reports and events: 261 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-11-0916:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-22-007291 |
| 2022-08-0816:06 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001104659-22-087222 |
| 2022-08-0816:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-22-005457 |
| 2022-07-1816:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-22-080483 |
| 2022-06-2316:03 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-073889 |
| 2022-06-1616:06 ET | 8-K | 5.07 Shareholder vote results | 0001104659-22-071880 |
| 2022-05-0516:06 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001104659-22-056442 |
| 2022-05-0516:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-22-003323 |
| 2022-04-2607:01 ET | DEF 14A | Proxy statementPeriod 2022-06-16 | 0001104659-22-049942 |
| 2022-02-2816:06 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001104659-22-028070 |
| 2022-02-2816:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-22-001448 |
| 2022-01-2816:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-22-008977 |
| 2021-11-0916:05 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001104659-21-136268 |
| 2021-11-0916:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-21-007741 |
| 2021-08-0516:07 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001104659-21-100745 |
| 2021-08-0516:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-21-005572 |
| 2021-07-1416:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-092099 |
| 2021-07-1216:01 ET | 8-K | 8.01 Other events | 0001104659-21-091151 |
| 2021-07-0116:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-21-088220 |
| 2021-06-1716:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-21-082585 |
| 2021-05-0616:06 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001104659-21-062387 |
| 2021-05-0616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-21-003256 |
| 2021-04-2716:06 ET | DEF 14A | Proxy statementPeriod 2021-06-17 | 0001104659-21-055589 |
| 2021-03-2916:06 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001104659-21-043161 |
| 2021-03-2916:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-21-002135 |
| 2021-01-0408:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-000104 |
| 2020-11-0616:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-122521 |
| 2020-11-0516:06 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001104659-20-121786 |
| 2020-11-0516:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-20-007664 |
| 2020-08-1816:01 ET | 8-K | 8.01 Other events | 0001104659-20-096505 |
| 2020-08-0616:21 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001104659-20-091459 |
| 2020-08-0616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-20-005651 |
| 2020-06-1816:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-20-074646 |
| 2020-06-1717:38 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-073843 |
| 2020-06-1516:10 ET | 8-K | 8.01 Other events | 0001104659-20-073386 |
| 2020-06-1216:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-20-072934 |
| 2020-05-0616:16 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001104659-20-057436 |
| 2020-05-0616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-20-003372 |
| 2020-04-2816:09 ET | DEF 14A | Proxy statementPeriod 2020-06-18 | 0001047469-20-002644 |
| 2020-03-2616:09 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001047469-20-001809 |
| 2020-03-2616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-20-002037 |
| 2019-11-1209:01 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001104659-19-062181 |
| 2019-11-1208:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-19-007429 |
| 2019-08-0716:06 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001104659-19-044531 |
| 2019-08-0716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-19-005251 |
| 2019-06-2416:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-19-037195 |
| 2019-06-2016:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-19-036671 |
| 2019-05-0716:31 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001104659-19-027513 |
| 2019-05-0716:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-19-003062 |
| 2019-04-2609:02 ET | DEF 14A | Proxy statementPeriod 2019-06-19 | 0001047469-19-002607 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 19:04 ET. Listed shows no prices and gives no investment advice.